Omega Therapeutics Inc. (NASDAQ: OMGA)
$2.09
+0.1350 ( +6.92% ) 360.7K
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. ItĀ operates in the U.S.
Market Data
Open
$2.09
Previous close
$1.95
Volume
360.7K
Market cap
$115.27M
Day range
$1.98 - $2.14
52 week range
$1.30 - $6.30
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Mar 28, 2024 |
10-k | Annual reports | 121 | Mar 28, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
4/a | Other | 1 | Feb 09, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
8-k | 8K-related | 58 | Jan 05, 2024 |